| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005792-197707000-00001 |
| P953 | full work available at URL | https://journals.lww.com/00005792-197707000-00001 |
| P698 | PubMed publication ID | 327194 |
| P2093 | author name string | C. M. Pearson | |
| R. L. Bowman | |||
| J. B. Peter | |||
| A. Bohan | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | computer-aided diagnosis | Q1122413 |
| dermatomyositis | Q681160 | ||
| polymyositis | Q980926 | ||
| P304 | page(s) | 255-286 | |
| P577 | publication date | 1977-07-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis | |
| P478 | volume | 56 |
| Q33620295 | A Rare Case of Necrotizing Myopathy and Fibrinous and Organizing Pneumonia with Anti-EJ Antisynthetase Syndrome and SSA Antibodies |
| Q64956901 | A Young Male with Severe Myocarditis and Skeletal Muscle Myositis. |
| Q61795716 | A case of diabetic myonecrosis: A rare complication of a common disease |
| Q40249962 | A case of erythrodermic dermatomyositis associated with gastric cancer |
| Q35672162 | A case study of gait compensations for hip muscle weakness in idiopathic inflammatory myopathy |
| Q72429662 | A clinical approach to systemic vasculitis |
| Q89601086 | A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level |
| Q38413380 | A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis |
| Q72030005 | Acquired cutaneous lymphangiectasia mimicking plantar warts |
| Q79796038 | Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study |
| Q33565968 | Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients |
| Q70622733 | Adult-onset mixed myopathy with nemaline rods, minicores, and central cores: a muscle disorder mimicking polymyositis |
| Q38675638 | An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis |
| Q51815023 | Anaesthetic management of a child with dermatomyositis. |
| Q35834820 | Animal model of human disease. Dermatomyositis. Familial canine dermatomyositis |
| Q34576940 | Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease |
| Q36245898 | Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis |
| Q70281004 | Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease |
| Q70440742 | Antibodies to Mi-1 in SLE: relationship to other precipitins and reaction with bovine immunoglobulin |
| Q55002581 | Antimitochondrial antibodies-positive myositis accompanied by cardiac involvement. |
| Q33553751 | Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies |
| Q42090926 | Apparent haematuria: an early sign in polymyositis |
| Q41718965 | Articular manifestations of polymyositis and dermatomyositis |
| Q46970163 | Asymmetrical weakness in polymyositis associated with neuropathic involvement |
| Q40104710 | Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine |
| Q57814514 | Autoimmune Myopathies: Updates on Evaluation and Treatment |
| Q37886653 | Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis |
| Q37296343 | Bilateral coxitis in scleroderma-polymyositis overlap syndrome |
| Q72097033 | Biopsy proven polymyositis in Victoria 1982-1987: analysis of prognostic factors |
| Q35618761 | Brief report: antisynthetase syndrome-associated myocarditis |
| Q50556739 | Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. |
| Q46235418 | Cardiac Transplantation in Dermatomyositis: A case report and literature review |
| Q72417668 | Cardiac abnormalities in polymyositis/dermatomyositis |
| Q71793176 | Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: clinical implications |
| Q28079786 | Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies |
| Q38030852 | Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. |
| Q40746214 | Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review |
| Q51780952 | Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients. |
| Q41387486 | Characterization of mononuclear exudates in idiopathic inflammatory myopathies |
| Q37009774 | Chronic focal polymyositis in the adult |
| Q52590882 | Classification of myositis. |
| Q34298818 | Clinical and serologic features of patients with polymyositis or dermatomyositis |
| Q37284770 | Clinical characteristics and outcomes of juvenile and adult dermatomyositis |
| Q37734933 | Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009. |
| Q37938701 | Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis |
| Q40154586 | Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases |
| Q70232740 | Clinical profiles of patients with antibodies to nuclear ribonucleoprotein |
| Q41303957 | Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases |
| Q42579510 | Coexistent dermatomyositis and autoimmune thyroiditis |
| Q41668447 | Complete Heart Block in Mixed Connective Tissue Disease |
| Q33561257 | Constrictive pericarditis complicating dermatomyositis |
| Q61410157 | Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis |
| Q33623753 | Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis |
| Q38649505 | Corticosteroids in Myositis and Scleroderma |
| Q38625526 | Current management of polymyositis and dermatomyositis |
| Q42114004 | Decreased plasma superoxide scavenging activity in immunological disorders — carboxyethylgermanium sesquioxide (Ge-132) as a promoter of prednisolone |
| Q36077890 | Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology. |
| Q37608074 | Dermatomyositis Leading to Necrotizing Vasculitis: A Perfect Response to Applied Therapy |
| Q42350840 | Dermatomyositis and HIV. |
| Q34535933 | Dermatomyositis and Polymyositis |
| Q36126081 | Dermatomyositis and rapidly progressive fibrosing alveolitis |
| Q36986876 | Dermatomyositis and supraventricular tachycardia |
| Q90641121 | Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer |
| Q53906999 | Dermatomyositis with calcinosis cutis. Case report 317. |
| Q34140461 | Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil |
| Q33562609 | Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis |
| Q70776220 | Development and long term prognosis of 50 cases of dermatomyositis and polymyositis |
| Q30249522 | Diagnosis and classification of idiopathic inflammatory myopathies |
| Q72809630 | Dysfunction of the sarcoplasmic reticulum in polymyositis |
| Q48333798 | Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography |
| Q36994516 | Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents |
| Q36656406 | Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study. |
| Q91923132 | Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis |
| Q40054698 | Eosinophilic Fasciitis:Review and Report of Six Cases |
| Q35907850 | Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan |
| Q68187871 | Experimental autoimmune myositis in SJL/J mice |
| Q35858418 | Familial canine dermatomyositis. Initial characterization of the cutaneous and muscular lesions |
| Q67247219 | Familial granulovacuolar lobular myopathy with electrical myotonia |
| Q70062014 | Familial myopathies with restricted distribution, facial weakness and inflammatory changes in affected muscles |
| Q74561766 | Frequent clonal expansion of peripheral T cells in patients with autoimmune diseases: a novel detecting system possibly applicable to laboratory examination |
| Q44557999 | Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection |
| Q34490287 | Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. |
| Q37601815 | Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders |
| Q33734484 | Heart transplant for dilated cardiomyopathy associated with polymyositis |
| Q36957220 | High-dose intravenous human immunoglobulin in polymyositis resistant to treatment |
| Q33578374 | Human leucocyte antigen typing in rheumatoid arthritis/polymyositis overlap syndrome |
| Q64104368 | Hypomyopathic Dermatomyositis Presenting with Idiopathic CD4 T-lymphocytopenia and Delayed Anti-MDA5 Positivity |
| Q30252086 | Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review |
| Q26744705 | Idiopathic Inflammatory Myopathies: Clinical Approach and Management |
| Q33564206 | Idiopathic myositis: a rheumatological view |
| Q72807252 | Immunohistochemical characterization of the mononuclear cells infiltrating muscle of patients with inflammatory and noninflammatory myopathies |
| Q39831068 | Immunological features of polymyositis/dermatomyositis |
| Q37208984 | Immunomodulatory treatment for dermatomyositis |
| Q72789635 | Impaired autologous mixed lymphocyte reaction with normal concanavalin A-induced suppression in adult polymyositis/dermatomyositis |
| Q53136101 | Inflammatory muscle disease assessment. |
| Q47650949 | Interstitial Pneumonia with Autoimmune Features: Overview of proposed criteria and recent cohort characterization |
| Q68826730 | Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis |
| Q72429398 | Joint involvement in polymyositis/dermatomyositis |
| Q62658334 | Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia |
| Q36041178 | Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups |
| Q35223951 | Laboratory evaluation of the inflammatory myopathies. |
| Q55332142 | Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositis. |
| Q35638147 | Long-term outcome in polymyositis and dermatomyositis |
| Q39824090 | Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle. |
| Q37629606 | Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. |
| Q58803312 | MRI-Guided Biopsy as a Tool for Diagnosis and Research of Muscle Disorders |
| Q54113361 | Major Depressive Disorder Following Dermatomyositis: A Case Linking Depression with Inflammation. |
| Q28253274 | Marker antibodies in scleroderma and polymyositis: clinical associations |
| Q35993982 | Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study |
| Q55279455 | Membranous glomerulonephritis, dermatomyositis, and bronchial carcinoma |
| Q34260708 | Morbidity and mortality in adult polymyositis and dermatomyositis |
| Q71807562 | Multiorgan Failure After Cardiac Arrest in a 20-Year-Old Man |
| Q33552700 | Muscle biopsy in polymyositis and dermatomyositis: a clinicopathological study |
| Q33869281 | Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres |
| Q35469372 | Myopathy with antibodies to the signal recognition particle: clinical and pathological features |
| Q37368405 | Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research |
| Q35105053 | Neuromuscular complications of cancer |
| Q92688792 | Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies |
| Q55277507 | New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter. |
| Q41261002 | New application of myocardial antimyosin scintigraphy: diagnosis of myocardial disease in polymyositis |
| Q35670637 | Novel Autoantigens Associated with Lupus Nephritis |
| Q36037364 | Organizing pneumonia as the first manifestation of anti-synthetase syndrome |
| Q33864271 | Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report |
| Q41352975 | Paraneoplastic Dermatomyositis Syndrome Presenting as Dysphagia |
| Q40584168 | Paraneoplastic manifestations in children |
| Q68952149 | Paraneoplastic rheumatic disorders: a review |
| Q34023610 | Paraneoplastic syndromes associated with lung cancer |
| Q70094616 | Paraneoplastic syndromes of the nervous system |
| Q40138620 | Paraneoplastic syndromes that involve the nervous system |
| Q28368015 | Penicillamine-Induced Dermatomyositis |
| Q33566780 | Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigens |
| Q46879738 | Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies |
| Q71669317 | Polymyositis |
| Q28361454 | Polymyositis after propylthiouracil treatment for hyperthyroidism |
| Q37790632 | Polymyositis associated with hypothyroidism or hyperthyroidism: two cases and review of the literature |
| Q36717070 | Polymyositis presenting as sick sinus syndrome |
| Q33563622 | Polymyositis, not polymyalgia rheumatica |
| Q38743596 | Polymyositis-dermatomyositis: a clinical review |
| Q35863342 | Polymyositis-dermatomyositis: diagnostic and prognostic significance of muscle alkaline phosphatase. |
| Q21134037 | Profound olfactory dysfunction in myasthenia gravis |
| Q46943629 | Prognosis and mortality of polymyositis and dermatomyositis patients |
| Q33332176 | Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome |
| Q33557157 | Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases |
| Q39817683 | Pulmonary manifestations of the rheumatic diseases |
| Q40110476 | Recent advances in polymyositis |
| Q41521239 | Recognition and Management of Myositis |
| Q35482545 | Recommended diagnostic criteria for paraneoplastic neurological syndromes |
| Q35826218 | Renal failure in a patient with autosomal dominant polycystic kidney disease and coexisting dermato-polymyositis: first report in the literature. |
| Q34644962 | Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial |
| Q37150812 | Role of regulatory T cells in a new mouse model of experimental autoimmune myositis |
| Q36245680 | Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity |
| Q36401965 | Serum proteins and paraproteins in women with silicone implants and connective tissue disease: a case-control study |
| Q77800084 | Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome |
| Q41177422 | Severe dermatomyositis treated with cyclosporin A. |
| Q40114367 | Skeletal muscle immunopathology |
| Q35564239 | Skin involvement in dermatomyositis |
| Q45260446 | Spontaneous electrical muscle fiber activity in polymyositis and dermatomyositis |
| Q34100509 | Sporadic viral myositis in two adults. |
| Q72778075 | Subcutaneous edema: an "unrecognized" feature of acute polymyositis |
| Q37305197 | Subscapular bursitis as a rare manifestation of dermatomyositis: a case report. |
| Q41532897 | Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease. |
| Q48143244 | Symptomatic arrhythmia in the form of multiple premature ventricular extrasystoles as the first symptom of polymyositis. |
| Q27004153 | Systemic lupus erythematosusmyositis overlap syndrome: report of 6 cases |
| Q34760525 | Tamoxifen-induced tumour regression associated with dermatomyositis |
| Q90729238 | The incidence of idiopathic inflammatory myopathies in the adult Slovenian population |
| Q37582578 | Ultrasound in the evaluation of the inflammatory myopathies |
| Q81753277 | [Dermatological symptoms in rheumatology] |
Search more.